The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy
- PMID: 17130355
- DOI: 10.1161/CIRCULATIONAHA.106.664169
The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy
Comment on
-
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.Circulation. 2006 Nov 28;114(22):2374-81. doi: 10.1161/CIRCULATIONAHA.106.642074. Epub 2006 Nov 20. Circulation. 2006. PMID: 17116766 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
